Saudi Arabia
· Delayed Price · Currency is SAR Dallah Healthcare Company Statistics
Total Valuation
Dallah Healthcare Company has a market cap or net worth of SAR 15.51 billion. The enterprise value is 17.55 billion.
| Market Cap | 15.51B |
| Enterprise Value | 17.55B |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | Aug 26, 2024 |
Share Statistics
Dallah Healthcare Company has 97.68 million shares outstanding. The number of shares has increased by 4.47% in one year.
| Shares Outstanding | 97.68M |
| Shares Change (YoY) | +4.47% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 9.66% |
| Owned by Institutions (%) | 3.85% |
| Float | 40.66M |
Valuation Ratios
The trailing PE ratio is 34.97 and the forward PE ratio is 31.83. Dallah Healthcare Company's PEG ratio is 1.65.
| PE Ratio | 34.97 |
| Forward PE | 31.83 |
| PS Ratio | 5.00 |
| PB Ratio | 4.60 |
| P/FCF Ratio | 47.29 |
| PEG Ratio | 1.65 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.48, with an EV/FCF ratio of 53.50.
| EV / Earnings | 39.56 |
| EV / Sales | 5.65 |
| EV / EBITDA | 24.48 |
| EV / EBIT | 30.12 |
| EV / FCF | 53.50 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.18 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 2.75 |
| Debt / FCF | 5.79 |
| Interest Coverage | 5.55 |
Financial Efficiency
Return on equity (ROE) is 13.37% and return on invested capital (ROIC) is 6.40%.
| Return on Equity (ROE) | 13.37% |
| Return on Assets (ROA) | 5.55% |
| Return on Capital (ROIC) | 6.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.50 |
| Inventory Turnover | 8.11 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.99% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +16.99% |
| 50-Day Moving Average | 161.26 |
| 200-Day Moving Average | 167.36 |
| Relative Strength Index (RSI) | 48.14 |
| Average Volume (20 Days) | 72,931 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dallah Healthcare Company had revenue of SAR 3.11 billion and earned 443.60 million in profits. Earnings per share was 4.54.
| Revenue | 3.11B |
| Gross Profit | 1.11B |
| Operating Income | 555.70M |
| Pretax Income | 482.52M |
| Net Income | 443.60M |
| EBITDA | 665.38M |
| EBIT | 555.70M |
| Earnings Per Share (EPS) | 4.54 |
Balance Sheet
The company has 143.03 million in cash and 1.90 billion in debt, giving a net cash position of -1.76 billion or -17.98 per share.
| Cash & Cash Equivalents | 143.03M |
| Total Debt | 1.90B |
| Net Cash | -1.76B |
| Net Cash Per Share | -17.98 |
| Equity (Book Value) | 3.65B |
| Book Value Per Share | 34.51 |
| Working Capital | 211.34M |
Cash Flow
In the last 12 months, operating cash flow was 667.11 million and capital expenditures -339.08 million, giving a free cash flow of 328.03 million.
| Operating Cash Flow | 667.11M |
| Capital Expenditures | -339.08M |
| Free Cash Flow | 328.03M |
| FCF Per Share | 3.36 |
Margins
Gross margin is 35.77%, with operating and profit margins of 17.90% and 14.29%.
| Gross Margin | 35.77% |
| Operating Margin | 17.90% |
| Pretax Margin | 15.54% |
| Profit Margin | 14.29% |
| EBITDA Margin | 21.43% |
| EBIT Margin | 17.90% |
| FCF Margin | 10.56% |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 0.94%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 0.94% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 42.29% |
| Buyback Yield | -4.47% |
| Shareholder Yield | -3.52% |
| Earnings Yield | 2.86% |
| FCF Yield | 2.11% |
Stock Splits
The last stock split was on September 14, 2020. It was a forward split with a ratio of 1.2.
| Last Split Date | Sep 14, 2020 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Dallah Healthcare Company has an Altman Z-Score of 4.57.
| Altman Z-Score | 4.57 |
| Piotroski F-Score | n/a |